Wegovy 0.5mg is approved for:

• Long-term weight management in adults with obesity (BMI of 30 or more)

• Weight management in adults with a BMI of 27 or more who also have weight-related health issues like type 2 diabetes, high blood pressure, or high cholesterol

Wegovy supports weight loss by mimicking natural hormones that regulate hunger. As a GLP-1 medication, it sends signals to your brain that you are full, helping you feel satisfied after smaller meals. It also slows down the movement of food through your stomach, which prolongs fullness and reduces cravings.

Wegovy influences GIP, another hormone involved in metabolism, which can help improve how your body handles nutrients and supports weight management.

Using a GLP-based approach like Wegovy provides consistent appetite control over time. Results appear gradually, allowing you to eat less without feeling deprived, which is essential for sustainable, long-term weight loss.

Before starting Wegovy, tell your doctor about all the medicines, supplements, or herbal products you're taking. Some combinations can cause serious side effects, especially when it comes to your blood sugar, blood pressure, or digestion.

Watch out for interactions with:

• Insulin or diabetes pills (like glimepiride or glipizide): These can lower your blood sugar too much when combined with Wegovy.

• Blood thinners (like warfarin): You may need extra monitoring, as weight loss can change how this medicine works.

• Thyroid medicine (like levothyroxine): Rapid weight loss might affect your thyroid levels.

• Water pills (diuretics): Combined weight and water loss can lead to dehydration or low blood pressure.

• Birth control pills: Wegovy might change how well these work if you get nauseous or vomit often.

Also, avoid taking other weight-loss drugs or similar injections unless your doctor says it's okay.

• Store your pen in the fridge (not the freezer), it should be kept between 2°C and 8°C.

• If you forget a dose, take it within 5 days. If it’s been longer, skip that dose and stick to your regular schedule.

• Never take two doses at once to make up for a missed one.

• Signs of overdose (like severe nausea or vomiting) need medical attention right away.

• Always keep the pen out of children’s reach and don’t share it, even if the needle is changed.

Wegovy 0.5mg, a GLP-1–based medication, is given once a week as an injection under the skin. You can inject it in your stomach, thigh, or upper arm, just rotate spots to avoid irritation. It can be taken with or without food.

For consistent results, use it on the same day each week. Your doctor or nurse will guide you on how to safely use this injection pen, ensuring proper technique and effectiveness.

Wegovy 0.5mg FlexTouch causes some side effects like all medications, although not everyone will experience them. 

Common side effects:

• Nausea

• Vomiting

• Constipation or diarrhoea

• Tiredness

• Headache

• Indigestion

• Bloating or gas

Serious side effects (get medical help if you notice these):

• Severe stomach pain or signs of pancreatitis

• Gallbladder issues (like pain in your upper belly or yellowing of the skin)

• Signs of kidney problems (such as less urination or swelling)

• Fast heart rate

• Allergic reactions (rash, itching, swelling, trouble breathing)

• Stick to a Weekly Routine: Take Wegovy 0.5mg FlexTouch on the same day each week. Use phone reminders or calendar alerts to avoid missing a dose.

• Rotate Injection Sites: To prevent skin irritation or lumps, inject into different spots on your abdomen, thigh, or upper arm each time.

• Manage Nausea Smartly: Eat small, balanced meals and avoid greasy or high-fat foods. This can help reduce nausea and improve digestion.

• Stay Hydrated: Drink plenty of water throughout the day to prevent dehydration, especially if you experience nausea, vomiting, or diarrhoea.

• Watch for Warning Signs: If you notice severe stomach pain, vomiting, or signs of an allergic reaction, seek medical help immediately. These could be signs of serious side effects like pancreatitis.

1. Novo Nordisk Inc, FDA Food and Drug Safety Administration [September 20, 2019] [Accessed date 18th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209637s032lbl.pdf 

2. Novo Nordisk Limited, EMC,  [25 Jan 2023], [Accessed date 18th August 2023] Electronic Medicines Compendium (EMC), [Revised on 25th Jan 2023] [Accessed on 18 August 2023] https://www.ema.europa.eu/en/documents/overview/ozempic-epar-summary-public_en.pdf 

3. https://www.wegovy.com/ 

4. https://cdscoonline.gov.in/CDSCO/cdscoDrugs